Data collection

IA Ibironke W. Apata
JC Jason Cobb
JN Jose Navarrete
JB John Burkart
LP Laura Plantinga
JL Janice P. Lea
ask Ask a question
Favorite

To assess the clinical characteristics of patients who were diagnosed with COVID-19, data were abstracted from the facilities’ electronic medical records. Clinical care and laboratory data were collected per routine dialysis procedures and protocol. Emory Institutional Review Board approval was obtained, and informed consent was waived. A patient with confirmed diagnosis of COVID-19 was defined as a patient with a documented positive SARS-CoV-2 viral test (PCR or antigen). Patients with COVID-19 from March 1, 2020 through May 31, 2020 were included. The follow-up period spanned March– June 30, 2020, to ensure all patients had at least 30 days of follow-up from a positive SARS-CoV-2 test result. We report the baseline characteristics of all patients receiving care at Emory dialysis (i.e. Emory general dialysis population) for the period March1, 2020 through May 31, 2020.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A